ERBB2 and breast cancer: The hypothesis, very important for its potential and practical consequences, in our opinion, should be further investigated by exposing breast cancer cells to concentrations of PUFA lower than those used in this study (100 and 200 μM), which, in the overexpressing HER2 SK-BR-3 cells, dramatically affected cell viability (by 20%–30% and 40%–70%, respectively, after 24–72 h) [67].